The Enterprise Value as of December 2025 (TTM) for AlzeCure Pharma AB (publ) (ALZCUR.ST) is 219.44M

According to AlzeCure Pharma AB (publ)’s latest financial reports and current stock price. The company's current Enterprise Value is 219.44M. This represents a change of 23.81% compared to the average of 177.23M of the last 4 quarters.

AlzeCure Pharma AB (publ) (ALZCUR.ST) Historical Enterprise Value (quarterly & annually)

How has ALZCUR.ST Enterprise Value performed in the past?

The mean historical Enterprise Value of AlzeCure Pharma AB (publ) over the last ten years is 98.52M. The current 219.44M Enterprise Value has changed 22.17% with respect to the historical average. Over the past ten years (40 quarters), ALZCUR.ST's Enterprise Value was at its highest in in the March 2018 quarter at 297.65M. The Enterprise Value was at its lowest in in the June 2019 quarter at -63274805.60.

AlzeCure Pharma AB (publ) (ALZCUR.ST) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of AlzeCure Pharma AB (publ) Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

AlzeCure Pharma AB (publ) (ALZCUR.ST) Average Enterprise Value

How has ALZCUR.ST Enterprise Value performed in the past?

The current Enterprise Value of AlzeCure Pharma AB (publ) (ALZCUR.ST) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

AlzeCure Pharma AB (publ) (ALZCUR.ST) Enterprise Value vs. Peers

How is ALZCUR.ST’s Enterprise Value compared to its peers?

AlzeCure Pharma AB (publ)’s Enterprise Value is less than Nanexa AB (publ) (308.64M), less than Mentice AB (publ) (384.09M), greater than Physitrack PLC (23.71M), less than Boule Diagnostics AB (publ) (394.50M), greater than Enorama Pharma AB (publ) (178.42M), greater than Karolinska Development AB (publ) (46.80M), greater than IRLAB Therapeutics AB (publ) (116.55M), greater than Klaria Pharma Holding AB (publ.) (164.76M), less than Lipum AB (publ) (336.26M), greater than AcuCort AB (104.48M),

Build a custom stock screener for AlzeCure Pharma AB (publ) (ALZCUR.ST) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like AlzeCure Pharma AB (publ) using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

AlzeCure Pharma AB (publ) (ALZCUR.ST) and other stocks custom spreadsheet templates

The easiest way to analyze a company like AlzeCure Pharma AB (publ) or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.